earnings
PE
NASDAQ · PETS
PetMed Express, Inc.
Healthcare · Medical - Pharmaceuticals
$1.60
Up+$0.02 (+1.25%)
Updated Sep 17, 2026, 10:33 PM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 61.38M
- P/E ratio
- -9.81
- Dividend yield
- 0.00%
- 52-week range
- $1.60 – $2.71
- Volume
- 75.5K
- Avg. volume
- 150.74K
Price performance
PETS price history
1M range · 20 trading sessions · Daily adjusted prices
PETS closed at $1.60 after 20 trading sessions, down 9.60% for the selected period.
- Last close
- $1.60
- Period change
- -9.60%
- Period low
- $1.60
- Period high
- $1.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.63 | $1.63 | $1.60 | $1.60 | 75.5K |
| Sep 15, 2026 | $1.68 | $1.68 | $1.61 | $1.62 | 123.98K |
| Sep 14, 2026 | $1.65 | $1.69 | $1.65 | $1.67 | 93.59K |
| Sep 11, 2026 | $1.71 | $1.7499 | $1.65 | $1.65 | 37.09K |
| Sep 10, 2026 | $1.70 | $1.745 | $1.675 | $1.70 | 138.35K |
| Sep 9, 2026 | $1.73 | $1.75 | $1.71 | $1.71 | 67.01K |
| Sep 8, 2026 | $1.81 | $1.81 | $1.74 | $1.76 | 64.17K |
| Sep 4, 2026 | $1.84 | $1.84 | $1.79 | $1.81 | 49.75K |
| Sep 3, 2026 | $1.87 | $1.87 | $1.785 | $1.85 | 172.29K |
| Sep 2, 2026 | $1.84 | $1.88 | $1.84 | $1.865 | 28.82K |
| Sep 1, 2026 | $1.88 | $1.88 | $1.81 | $1.83 | 64.47K |
| Aug 31, 2026 | $1.88 | $1.9202 | $1.8654 | $1.89 | 69.99K |
| Aug 28, 2026 | $1.83 | $1.925 | $1.83 | $1.88 | 70.03K |
| Aug 27, 2026 | $1.81 | $1.87 | $1.785 | $1.85 | 67.35K |
| Aug 26, 2026 | $1.75 | $1.81 | $1.7408 | $1.79 | 101.72K |
| Aug 25, 2026 | $1.75 | $1.77 | $1.75 | $1.76 | 26.32K |
| Aug 24, 2026 | $1.76 | $1.7681 | $1.735 | $1.75 | 52.48K |
| Aug 21, 2026 | $1.78 | $1.78 | $1.7501 | $1.76 | 50.35K |
| Aug 20, 2026 | $1.77 | $1.78 | $1.75 | $1.76 | 58.32K |
| Aug 19, 2026 | $1.79 | $1.83 | $1.77 | $1.77 | 86.76K |
Latest PETS news
The latest Smart Investors Daily articles mentioning PETS.
Stock researchResearch & News · Analysis
Loading stock research…

